The use of blood coagulation laboratory parameters for assessment of bleeding risk during radiofrequency ablation procedure in atrial fibrillation patients receiving dabigatran etexilate

The article presents the results of the analysis of hemostasis parameters in atrial fibrillation patients with and without anticoagulation therapy with dabigatran etexilate in the perioperative period of the arrhythmia ablation. We evaluated the capabilities of using the conventional indicators of the blood coagulation in atrial fibrillation patients receiving dabigatran etexilate to assess the possible risk of bleeding in the perioperative period of radiofrequency ablation.